Sponsor
TCR2 Therapeutics
Status of enrollment
Not yet accepting new patients
Ages Eligible for Study
Adults ages 18 and up
Genders Eligible for Study
Females and Males
Disease indication
Mesothelioma, Ovarian Cancer, Non Small Cell Lung Cancer, Triple Negative Breast Cancer
Principal Investigator
David Oh, MD, PhD
Contact
AAhir Srinath: [email protected]
Additional study eligibility details can be found at UCSF Clinical Trials.